16-50673942-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182854.4(SNX20):c.415G>A(p.Glu139Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182854.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNX20 | NM_182854.4 | c.415G>A | p.Glu139Lys | missense_variant | Exon 4 of 4 | ENST00000330943.9 | NP_878274.1 | |
SNX20 | NM_153337.3 | c.282+1828G>A | intron_variant | Intron 3 of 3 | NP_699168.1 | |||
SNX20 | NM_001144972.2 | c.282+1828G>A | intron_variant | Intron 3 of 3 | NP_001138444.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNX20 | ENST00000330943.9 | c.415G>A | p.Glu139Lys | missense_variant | Exon 4 of 4 | 1 | NM_182854.4 | ENSP00000332062.4 | ||
SNX20 | ENST00000423026.6 | c.282+1828G>A | intron_variant | Intron 3 of 3 | 1 | ENSP00000388875.2 | ||||
SNX20 | ENST00000568993.5 | n.282+1828G>A | intron_variant | Intron 3 of 4 | 1 | ENSP00000454863.1 | ||||
SNX20 | ENST00000300590.7 | c.282+1828G>A | intron_variant | Intron 3 of 3 | 2 | ENSP00000300590.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.415G>A (p.E139K) alteration is located in exon 4 (coding exon 3) of the SNX20 gene. This alteration results from a G to A substitution at nucleotide position 415, causing the glutamic acid (E) at amino acid position 139 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.